Home > PE Ratio > LAURUS LABS

LAURUS LABS
PE (Price/Earnings) Ratio

The Current P/E Ratio of LAURUS LABS is 161.52.

Share Price ₹586.6Feb 03,2025
Market Cap ₹31,635.3 Cr
Earnings-TTM₹195.9 CrTTM-Consolidated Results
Price/Earnings161.52xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for LAURUS LABS
Please provide your vote to see the results
LAURUS LABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of LAURUS LABS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of LAURUS LABS is calculated as :

Current Market Cap [ ₹31,635.3 Cr] as on Feb 03,2025

(/) Earnings [ ₹195.9 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 161.52x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for LAURUS LABS , the investors are currently willing to pay 161.52 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LAURUS LABS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of LAURUS LABS over the last five years.

Historical PE (Price/Earnings) ratio chart of LAURUS LABS


PE Ratio Performance Analysis for LAURUS LABS

- LAURUS LABS 's latest p/e ratio is 161.52x.

- LAURUS LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 42.96x.

- LAURUS LABS 's operated at median p/e ratio of 20.12x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LAURUS LABS 's p/e ratio peaked in Mar2024 at 133.9x.

- LAURUS LABS 's p/e ratio hit its five-year low in Mar2020 of 2.7x.


How does LAURUS LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
LAURUS LABS 195.86161.5231,635.3
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0036.35417,472.0
CIPLA LTD5,000.4322.95114,754.0
DR REDDYS LABORATORIES LTD5,428.6018.51100,465.0
ZYDUS LIFESCIENCES LTD4,298.9022.5396,875.2
DIVIS LABORATORIES LTD2,067.0075.64156,342.0
MANKIND PHARMA LTD2,050.7351.98106,597.0
TORRENT PHARMACEUTICALS LTD1,862.0057.59107,226.0
LUPIN LTD2,651.9434.9992,786.6
AUROBINDO PHARMA LTD3,598.8318.1965,453.4
ABBOTT INDIA LTD1,284.6643.0155,256.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LAURUS LABS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.19x
Max industry PE 161.52x
Median industry PE 36.35x
Average industry PE 49.39x



You may also like the below Video Courses